Literature DB >> 3484808

The vascular permeability factor is a T lymphocyte product.

J M Heslan, A Branellec, J Laurent, G Lagrue.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3484808     DOI： 10.1159/000183664

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  9 in total

Review 1.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

2.  Focal segmental glomerulosclerosis complicating solitary kidney.

Authors:  Yoshiyuki Oshiro; Sachio Umena; Masatoshi Noda
Journal:  Clin Exp Nephrol       Date:  2008-08-09       Impact factor: 2.801

3.  Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome.

Authors:  J M Heslan; A I Branellec; Y Pilatte; P Lang; G Lagrue
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation.

Authors:  Svetlana P Chapoval; Chun Geun Lee; Chuyan Tang; Achsah D Keegan; Lauren Cohn; Kim Bottomly; Jack A Elias
Journal:  Clin Immunol       Date:  2009-06-24       Impact factor: 3.969

Review 5.  Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.

Authors:  Virginia J Savin; Mukut Sharma; Jianping Zhou; David Genochi; Ram Sharma; Tarak Srivastava; Amna Ilahe; Pooja Budhiraja; Aditi Gupta; Ellen T McCarthy
Journal:  Biomed Res Int       Date:  2017-08-10       Impact factor: 3.411

6.  Changes in DNA methylation in naïve T helper cells regulate the pathophysiological state in minimal-change nephrotic syndrome.

Authors:  Yasuko Kobayashi; Akira Aizawa; Takumi Takizawa; Katsuhide Igarashi; Izuho Hatada; Hirokazu Arakawa
Journal:  BMC Res Notes       Date:  2017-09-15

7.  DNA methylation changes between relapse and remission of minimal change nephrotic syndrome.

Authors:  Yasuko Kobayashi; Akira Aizawa; Takumi Takizawa; Chikage Yoshizawa; Hiromi Horiguchi; Yuka Ikeuchi; Satoko Kakegawa; Toshio Watanabe; Kenichi Maruyama; Akihiro Morikawa; Izuho Hatada; Hirokazu Arakawa
Journal:  Pediatr Nephrol       Date:  2012-08-02       Impact factor: 3.714

Review 8.  Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease.

Authors:  Byung-Soo Kim; Michael S Goligorsky
Journal:  Korean J Intern Med       Date:  2003-06       Impact factor: 2.884

9.  Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.

Authors:  Sophie Doublier; Cristina Zennaro; Luca Musante; Tiziana Spatola; Giovanni Candiano; Maurizio Bruschi; Luca Besso; Massimo Cedrino; Michele Carraro; Gian Marco Ghiggeri; Giovanni Camussi; Enrico Lupia
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.